Electrogenics Laboratories – ATC 2020 Winner

Electrogenics has the technology to fill a major unmet need in the Radiotherapy / Radiology Markets:

1 – Safety of medical radiation procedures is subject to ongoing reviews.

2 – Existing radiation technology for the treatment of cancer is very complex and relies on computer control.

3 – There is no precise easy to use method to independently measure radiation skin dose is available.

4 – Advanced radiation delivery technology is not matched by independent Quality Assurance technology.

The MOSkinTM Technology fills a major unmet need in the radiotherapy and radiology markets.

The MOSkinTM Technology is an advanced MOSFET detector and packaging technology prototyped and developed at the CMRP at UOW that addresses these needs Electrogenics has the exclusive global license to the MOSkinTM Technology.

MOSkinTM is a novel MOSFET detector and packaging technology prototyped and developed at the Center for Medical Radiation Physics (CMRP), UOW, Australia.

Electrogenics Laboratories has the exclusive global license to the technology.

There is an increasing emphasis on Dosimetry during Radiotherapy Treatments.

This is because

1 – Increasingly complex systems and software are being integrated with radiotherapy equipment.


2 – There is a drive to increased efficiency through increasing per treatment dose and reducing number of radiation fractions required per patient.


3 – There is a recognised need for independent dose verification.

BUT

Currently available dosimetry systems have significant barriers that have restricted their use by clinicians in more cases.

A. They are difficult and time consuming to calibrate and use.

B. They do not provide precise real time feedback of delivered dose.

C. They are expensive for routine use and are not single use / disposable

Severe toxicity of the skin because of skin radiation doses exceeding the threshold